◆英語タイトル:Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011926
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The university spans its expertise in cancer research, neuroscience and neurodegenerative diseases, diabetes, stem cell therapy, epidemiology, Middle Eastern studies, materials science, and nanotechnology among others. It works in collaboration with other universities through international networks, cooperation platforms for research and education. LNU is headquartered in Lund, Sweden.
Lund University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Lund University, Medical Devices Deals, 2011 to YTD 2017 9
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lund University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RhoVac Enters into Research Agreement with Lund University 11
Rocket Pharma Entered into Research and Development Agreement with Lund University 12
Licensing Agreements 13
Avrobio Enters into Licensing Agreement with Lund University 13
Equity Offering 14
Akuru Pharma Spin Out from Lund University 14
Lund University – Key Competitors 15
Lund University – Key Employees 16
Lund University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Recent Developments 19
Government and Public Interest 19
Nov 30, 2017: Prestigious ERC grants awarded to Lund researchers 19
Nov 28, 2017: Molecular profiling of melanoma tumours explains differences in survival after T cell therapy 21
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 23
Nov 02, 2017: New research shows where in the brain the earliest signs of Alzheimers occur 25
Oct 25, 2017: New method helps rule out heart valve infection 27
Oct 05, 2017: Discovery of a new fusion gene class may affect the development of cancer 28
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 29
Jan 30, 2017: Unique mapping of methylome in insulin-producing islets 33
Oct 29, 2016: Breakthrough in the production of dopamine neurons for Parkinson’s disease 34
Jun 30, 2016: Lund University: Antidiabetic effects discovered in the appetite hormone CART 35
May 10, 2016: New technique can provide better cell transplants against Parkinson’s disease 36
Apr 20, 2016: Lund University: Using targeted missiles against aggressive cancer cells 37
Apr 13, 2016: Cartilage protein may contribute to the development of breast cancer 38
Product News 39
May 29, 2017: New test method aims to predict allergenic potency of chemicals 39
Other Significant Developments 40
Feb 06, 2017: An Innovative Medicines Initiative Project for Precision Medicine in DKD 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Lund University, Pharmaceuticals & Healthcare, Key Facts 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lund University, Deals By Therapy Area, 2011 to YTD 2017 8
Lund University, Medical Devices Deals, 2011 to YTD 2017 9
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RhoVac Enters into Research Agreement with Lund University 11
Rocket Pharma Entered into Research and Development Agreement with Lund University 12
Avrobio Enters into Licensing Agreement with Lund University 13
Akuru Pharma Spin Out from Lund University 14
Lund University, Key Competitors 15
Lund University, Key Employees 16
Lund University, Other Locations 17
Lund University, Subsidiaries 17
Lund University, Joint Venture 18